A pilot randomized study comparing non-immersive virtual reality–based upper- and lower-limb rehabilitation plus conventional therapy versus conventional therapy alone in post-stroke patients

A pilot randomized controlled study on the effectiveness of non-immersive virtual reality–based rehabilitation plus conventional occupational therapy versus conventional occupational therapy alone in improving upper- and lower-limb recovery in post-stroke hemiparetic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12954640

Enrollment

Registered

2026-02-09

Start date

2023-09-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper- and/or lower-limb motor impairment and functional limitation following stroke (post-stroke hemiparesis) Nervous System Diseases

Interventions

Participants are randomized into two parallel groups. The control cohort receives conventional occupational therapy only. The intervention cohort receives non-immersive virtual reality–based rehabilit

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–80 years 2. Unilateral upper-extremity hemiparesis/hemiplegia 3. Medically stable 4. Brunnstrom stage ranging from 2 to 4 5. Modified Ashworth Scale <2 6. Adequate visual acuity (with corrective lenses if needed) 7. No visual neglect, apraxia, or visuospatial perceptual disorders (screened via MMSE visuospatial item and therapist-administered clock-drawing test)

Exclusion criteria

Exclusion criteria: 1. History of other neurodegenerative diseases 2. Epilepsy 3. Cardiac pacemaker 4. Severe visual impairment 5. Known case of fracture on the affected side

Countries

India

Contacts

Public ContactSandipan Roy

me21s078@smail.iitm.ac.in+91 (0)7980965924

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026